Item

Interventional treatment group

Chinese herb group

Sex

 

 

Male

56

60

Female

9

7

Age (years)     

 

 

Median

51

51

Range

25-75

16-83

Serum hepatitis B surface antigen        

 

 

Positive

58

59

Negative

7

8

Serum AFP (ng/mL)

 

 

<20

18

15

21-400

6

6

≥400

41

46

Child-Pugh Classification                 

 

 

A

51

43

B

14

24

Portal vein thrombosis

 

 

Positive

45

44

Negative

20

23

ECOG performance status

 

 

1

40

29

2

22

31

3

3

7

Tumor burden (tumor/non-tumor)

 

 

≥50%

41

36

<50%

24

21

The number of tumor

 

 

1

37

30

≥2

28

37

Abdominal lymph node metastasis

 

 

Positive

27

29

Negative

38

38

Distant metastasis

 

 

Positive

18

26

Negative

37

41

AFP, alpha-fetoprotein; ECOG, the Eastern Cooperative Oncology Group
Table 1: General data of advanced HCC patients in interventional treatment group and Chinese herb group.